Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Jan. 29, 2022   225,100,000      
Beginning balance at Jan. 29, 2022 $ 7,718.5 $ 2.2 $ 1,243.9 $ (35.2) $ 6,507.6
Statement of Stockholders' Equity [Roll Forward]          
Net income 536.4       536.4
Total other comprehensive income (loss) (0.1)     (0.1)  
Issuance of stock under Employee Stock Purchase Plan 2.9   2.9    
Stock-based compensation, net (in shares)   500,000      
Stock-based compensation, net $ (2.0)   (2.0)    
Repurchase of stock (in shares) (89,779) (100,000)      
Repurchase of stock $ (14.2)   (14.2)    
Ending balance (in shares) at Apr. 30, 2022   225,500,000      
Ending balance at Apr. 30, 2022 8,241.5 $ 2.2 1,230.6 (35.3) 7,044.0
Beginning balance (in shares) at Jan. 28, 2023   221,200,000      
Beginning balance at Jan. 28, 2023 8,751.5 $ 2.2 667.5 (41.2) 8,123.0
Statement of Stockholders' Equity [Roll Forward]          
Net income 299.0       299.0
Total other comprehensive income (loss) (2.8)     (2.8)  
Issuance of stock under Employee Stock Purchase Plan 2.9   2.9    
Exercise of stock options 0.1   0.1    
Stock-based compensation, net (in shares)   400,000      
Stock-based compensation, net 1.1   1.1    
Repurchase of stock (in shares)   1,000,000.0      
Repurchase of stock $ 152.1   152.1    
Repurchase of stock (in shares) (1,025,000)        
Repurchase of stock $ (151.1)        
Ending balance (in shares) at Apr. 29, 2023   220,600,000      
Ending balance at Apr. 29, 2023 $ 8,899.7 $ 2.2 $ 519.5 $ (44.0) $ 8,422.0